SUGGESTED IDEAL INTAKE PER DR. KELLEY: (this information is on the label of the bottle)

ON CYCLE TAKE: Above recommended PROTOCOL A, B OR C. If uncertain begin with PROTOCOL C for 1 WEEK, B for 1 WEEK working up to PROTOCOL A by 3rd WEEK using the guidelines below:

Take supplements up to 25 days. STOP taking supplements if you experience discomfort of any kind, you may stop taking after 3 to 5 days on, but it is best to continue for 25 days. DO NOT EXCEED 25 DAYS ON CYCLE.

OFF CYCLE: Remain off supplements for 5 days. You must give the body time to adjust. Stay OFF supplements the full 5 days even if you feel well enough to continue.

Continue Cycling ON/OFF for 9 to 18 months. Then TAKE 4 to 6 Capsules with meals and 1 with snacks as long as you choose to metabolically support your being.

All of us in the Health Community applaud Dr. Gonzalez for his breakthrough achievement in the NCI grant of $1.4 million for the pancreatic cancer trial. This marvelous accomplishment, however, began in 1906 at the University of Edinburgh, Scotland through Professor John Beard, an embryologist. Beard discovered the anti-cancer effect of pancreatic enzymes with mice and recommended it for humans. Several cancer cures were reported in the American Medical Journal by respected physicians. In 1911 the x-ray technology came into being, and pancreatic enzymes were abandoned for Marie Curie's radiation discovery.

In 1969, a Texas orthodontist, William Donald Kelley lay on the operating table for pancreatic cancer. It was inoperable. Kelley was told to go home and get his affairs in order. He had three months to live. Kelley refused to surrender. He researched the medical literature and found Beard's pancreatic enzymes.
The rest is history. There would be six other cases of pancreatic cancer that recovered past five years under Kelley's Program of pancreatic enzymes, detoxification, and individualized nutrition. Over 5,000 patients of varying auto - immune diseases and cancer responded to Kelley's immune regeneration in the next fifteen years. Unfortunately, a dentist curing cancer does not sit well with the medical establishment and Kelley was forced to retire. Dr. Kelley turned over his records, knowledge, programs, and "torch" to a very promising immunologist - medical doctor in New York, N.Y., Nicholas Gonzalez, M.D. in 1986. Note: Dr. Tate trained under Dr. Kelley in 1982 - 1984.

~ What is Cancer? ~
Cancer is a process misunderstood by the medical community. Cancer is classified by the medical community, as a fast-growing malignant tumor, which, if allowed to grow unchecked, will cause death. Many clinicians believe that cancer is a complex: a number of different diseases, each having it's own cause. Most doctors, even research scientists, suppose such things as viruses, X-rays cigarette smoking chemicals, sunlight, and trauma causes cancer. However there are a growing number of cancer researchers who believe that these factors, rather than causing cancer, are indirect stimulators of a normal trophoblast-like pleuripotential cell. This trophoblast-like cell then makes its "faIse placenta", a malignant tumor mass, which the medical community calls cancer.

~ In the Beginning ~
In the first five days after fertilization in the formation of a human embryo, the growing mass of cells divides into two kinds of cells, an inner cell mass (embryoblasts) which become the embryo, and an outer layer of cells called the trophoblast, which later forms the placenta. This process is so complex that half of the developing masses ever progress past this stage. Something goes wrong with normal development and they are expelled from the woman's body before they can implant themselves in the uterus.

After the cell mass attaches to the wall of the uterus, the trophoblasts invade the lining of the uterus, growing quickly and invasively, as a tumor does when invading an organ of a human body. The trophoblast cells invade, digest a bole in the wall of the uterus and form a multinucleated mass with no cell boundaries, which looks under the microscope like the cells of a carcinoma. During this invasion of the trophoblasts into the uterine wall, the pregnant woman may feel nauseous with "morning sickness" due to the trauma of being assailed by this cancer-like mass. As small blood vessels are invaded and digested by the invading trophoblasts, pools of blood form in the tissue, which nourishes the growing mass. The failure of the maternal tissue to reject this implantation has always puzzled embryologists and immunologists. One current view is that the trophoblast cells lack certain protein on their surfaces, and thus are not recognized as foreign by the mother's body.

~ Primary Germ Cell ~
During the time that the trophoblast cells are aggressively infiltrating the maternal tissue, the inner cell mass is organizing itself into a three part disc, shaped like I flying saucer. These three parts of the disc are called the three primary germ layers, or the ectoderm, the endoderm and the mesoderm. Each of these three layers become different parts of the human body .The ectoderm becomes the skin, the brain and the nerves. "Ecto" means surface, and indeed these cells become the surface covering of the body, and the nerves which are the interface, of the body with the outside world. The endoderm becomes the linings of many organs) such as the lungs, the intestines, liver, and pancreas "Endo" means within, and indeed these cells become almost all of the linings of the body. The mesoderm becomes the muscles, blood, bone, and the reproductive organs. "Meso" means middle, and these mesoderm cells, which form as the middle layer of the disc, become the vast majority of the cells of the body, almost all of the different cell types.

This process of organ formation involves extensive migration of certain cells from the disc to their future sites. The mesoderm cells come from an area on the disc known as the primitive streak. Under a microscope, a dark streak progresses visibly along the center of the disc from the tail end to the head end of the disc. This primitive streak is caused as ectodermal cells drive down into the middle of the disc like the filling of a sandwich, becoming mesodermal cells in the process. This migrating of ectodermal cells becoming mesodermal cells happens very early in development - between two weeks and three weeks after the trophoblasts begin invading the uterus of the mother. These migrating cells, which come from the primitive streak, are pleuripotent. The mesoderm cells are called pleurlpotential, because under different circumstances they are able to follow more than one pathway of development. In other words, mesoderm cells can potentially form many kinds of tissue. They are cells, which are closest in nature to the unruly aggressive trophoblastic cells that have formed the placenta.

This broad developmental potential of the pleuripotential cells becomes more and more restricted and checked as the tissues acquire the specialized control mechanisms to guide the cells in their development. Increasingly complicated migrations of cells occur as the body of the new human is forming. For instance in the ectoderm, neural cells migrate in the myriad directions and become specialized neurons. This regimentation of a cell's capabilities must occur in order to form, for example, a bone cell as opposed to a muscle cell in the mesoderm. Such regimentation comes about in response to cues from the immediate surroundings, including the nearby tissue. The precision and coordination required for correct development is dependent upon these interactions. Thus, nearby tissues influence development of certain cells, probably by signals carried by certain protein molecules. Interestingly enough, these signals must also occur at a certain precise time, so that a delay in this signal may lead to the failure of correct interaction, leading to various kinds of defects. Many of these defects cause the death of the developing embryo, and some lead to birth defects.

~ Direct Cause of Cancer ~
The intricate and precise orchestration of the formation of a normal human from the original inner cell mass is a miracle of precision timing and maturation of these pleuripotential cells. Every normal human contains varying numbers of cells, which have not completed their correct migrations, thereby leaving "sleeping" pleuripotential cells scattered throughout the body. When these pleuripotential cells are activated through genetic, environmental or nutritional factors, a tumor cell mass, similar to the invasive trophoblastic cell mass can begin to form. This cancerous tumor may contain various types of tissue, such as chips of bone or hair. These scattered pleuripotential cells are normally prevented from becoming a cancerous tumor through circulating protein molecules, which keep their growth in check. It has been theorized that when a human body does not have enough of these patrolling molecules, the pleuripotential cell grows in an unrestrained fashion, becoming a carcinoma.

In summary, the early embryo has two cell types: the trophoblast and the embryoblast. The embryoblast becomes the three germ cell types; the ectoderm, the endoderm and the mesoderm. The mesodermal cells are pleuripotential, with a vast ability to become many different kinds of cells. Some of these remain "sleeping" dispersed throughout the tissues of the body.

~ How Do Enzymes Work? ~
Enzymes are normally produced by the pancreas to help digest the food that enters the small intestine from the stomach. Different kinds of enzymes work on protein, on fats or on starch and sugar. By the action of these powerful enzymes, large particles of protein, fat or starch, are broken down into smaller and smaller pieces, until they are small enough to go through the wall of the small intestine and be used there to digest food coming back from the stomach. These enzymes can also be absorbed through the wall of the small intestine into the body, and travel in the blood stream to distant locations in the body where they are needed.

Why don't these powerful enzymes start dissolving the very tissue that they are passing through? How can these enzymes travel to the tumor and only digest the cancer, without harming the person's body in which the cancer is growing? The secret to how the enzyme can tell the difference between "good tissues and bad tissues", lies in a difference as small as the difference between your right hand and your left hand. Almost all the billions of tiny molecules in the body are either right-handed or left-handed. As an example of right and left handedness, let's look at a pair of mittens. In a pair of mittens you find one for the right hand and one for the left hand. They are mirror images of each other, but if you tried to put the right-handed mitten down on top of the left-handed mitten, they would not match. In a mysterious way, the human body uses only right handed sugar molecules, but only left-handed protein molecules.

The above paragraph has discussed right-handed sugar molecules and left-handed protein molecules. Logic raises the question, where are the mirror image substances? Where are the left-handed sugar molecules and the right-handed protein molecules? These are found within the placenta, which is made of trophoblasts. They are also found within the trophoblast-like tumor cells. What difference does this make for the enzyme trypsin?

We know that the enzyme trypsin acts on cooked left-handed proteins and living (non-cooked) rlght-handed proteins. Normally, when we eat a meal, the cooked left-handed proteins, which we eat, are digested in the small intestine by the trypsin released by the pancreas. Trypsin does not act on the organs of the human body, because these are living, left-handed protein. However, trypsin is very effective at breaking down living, right-handed proteins. And where did we say living right-handed proteins could be found? These living, right-handed proteins are the substance comprising the cancerous tumor. So, the trypsin can travel via the bloodstream to the tumor, and its action there is on the protein mass that makes up the tumor. It breaks down the protein mass of the tumor and "liquefies" it.

As further explanation, this cancerous tumor needs an enzyme with which it can digest the organ or tissue of the human where the tumor is located. It uses human tissue as food. To obtain its needed enzyme, the tumor itself makes the enzyme. This tumor-made enzyme is called malignin, which does digest human protein. This malignin is the mirror image enzyme to trypsin. In other words, trypsin and malignin are mirror images of each other, as your right hand and left hand are mirror images of each other. As trypsin acts on living right-handed protein, namely the tumor mass, so malignin acts only on living left-handed proteins, namely human tissue.

Trypsin in sufficient quantities can begin to break down the cancerous tumor but not fully digest the cancerous tumor. During the breakdown process, trypsin produces some intermediate proteins, which can be quite toxic to the human body. These intermediate proteins need a second enzyme to complete their digestion, i.e. "liquefaction". Therefore, to be successful, the enzyme treatment for cancerous tumors must include both of these enzymes in sufficient quantities to render the products of tumor digestion harmless.

These enzymes work by traveling through the bloodstream to the site of the tumor and digesting the specific protein of the tumor mass, without harming the body's tissues at all. This fascinating story of the matching rlght and left handed molecules, trypsin and malignin, was explained almost a century ago by Scottish doctor, John Beard, D.Sc. His revolutionary book, published In London in 1911, was entitled, The Enzyme Treatment of Cancer and Its Scientific Basis. At that time, some cancers were treated by direct injection of the enzymes near the cancer mass. Now, we realize that injecting the enzymes is unnecessary, since swallowing capsules containing the enzymes will also work. Trypsin will only digest the protein of the tumor, thus it can safely travel through the body.

The ability to target the tumor in such a specific and successful manner makes the use of surgery, chemotherapy and radiation obsolete.
Kathy P. Fairbanks, Ph.D.

~ A Note from Dr. Kelley ~

Professor Fairbanks' scientific presentation above is pure truth and scientific without error. Any clinician who challenges this should start all over with his education - in high school biology.

I first read Dr. Beard's book in May 2000. By 1962 I bad developed my successful protocol and was free of cancer. I accept Professor Fairbanks' most significant contribution to the understanding of my program, which should help the clinicians who stand up for proper treatment of those suffering with cancer.

The missing factors in Dr. Beard's and Professor Fairbanks' understanding are the enzyme activators, which have made my program so successful for the past 40 years. It has been my experience that without the complete program, success will be limited to approximately 52%.

This article originally appeared in the February/March 1996 issue of the Townsend Letter for Doctors & Patients and is reprinted with permission of Robert Crayhon, M.S., and of the Townsend Letter for Doctors & Patients, 911 Tyler Street, Port Townsend, WA 98368-6541; (360) 385-6021: Fax (360) 385-0699; Email: tldp@olympus.net

Nicholas Gonzalez, M.D., is a practicing physician in New York City who specializes in treating cancer with a treatment originated by Dr. Kelley, D.D.S. He has a unique perspective on nutrition, autonomic nervous system balance and biochemical individuality. He joined Robert Crayhon for the June 16, 1995 taping of the national TV show, "Alternative Medicine." His address: 36 East 36th Street, Suite 204, New York, N.Y. 10016. His office phone number is 212-213-3337.

RC: Dr. Gonzalez, how did you start approaching cancer from your unique comprehensive metabolic and nutritional approach?

NG: I was a second year medical student intending to become chief of medicine at Sloan Kettering, and a friend of mine introduced me to Dr. Kelley, the infamous dentist who developed this elaborate nutritional approach to cancer. Skeptically, I approached him, and he said, "All I ever wanted was someone from the orthodoxy to look through my records." At the time, my research advisor at Cornell, where I was a medical student suggested I do it as a summer project. It evolved into a five year research study. We went through ten thousand of Kelley's records, and found that this man had indeed reversed advanced metastatic cancer. We went through the cases of thousands of patients.

RC: The way Dr. Kelley started-- correct me if I’m wrong-- was when he found out he had pancreatic cancer he walked into a health food store and bought pancreatic enzymes. The whole thing began by chance.

NG: That's right. It was purely by chance. He had a lot of digestive problems, as patients with pancreatic cancer will. In an attempt to help his digestive problems, he started taking huge doses of pancreatic enzymes and immediately felt a change in his tumor. That's how it started.

RC: There are many facets to the therapy that you do, but pancreatic enzymes are-- you believe-- the most powerful anticancer substances available. Why are they so anti-cancer?

NG: It’s the way the body is designed. In orthodox and even unorthodox physiology, we tend to think that the enzymes serve one function: to help to digest food. Indeed they do that. But Kelley-- as did many researchers before him and since-- believed that the enzymes are a primary defense against cancer, and are far more important than the immune system in terms of controlling the development and growth of cancer. So we believe that is one of their designated functions in the human body.

RC: Critics of this will say, "Pancreatic enzymes released into the digestive tract are molecules way too big to get into the bloodstream."

NG: In the 1940s, scientists documented that they do in fact get absorbed. There is a wonderful study from 1976 in Science magazine, one of the ultimate scientific journals, where a professor at Cornell did a study with rabbits and mice and found that the pancreatic enzymes are absorbed through the intestinal tract, complete and active, and are not destroyed in the gut.

RC: Are there any studies on pancreatic enzymes' anti-cancer activity?

NG: Yes. There is a wonderful study from 1965 where a doctor used them in animal models and a doctor found they had an extraordinary, powerful anti-cancer effect.

RC: Now these are inexpensive substances, aren't they, compared to pharmaceuticals?

NG: Yes.

RC: Why hasn't there been a greater interest in pancreatic enzymes? I know they were studied for nearly a hundred years. Is it because they were overshadowed by the work of Madam Curie, and the belief her work generated that radiation would cure all cancer? Or is it because pancreatic enzymes are unpatentable?

NG: Because of FDA regulations, pancreatic enzymes fall in the category of a natural substance. Therefore, there is no impetus for a drug company to spend hundreds of millions of dollars in researching pancreatic enzymes. They cannot patent what they might find. There is also the psychological resistance to look at natural substances in the orthodox research community, although that is starting to change.

RC: I know that your practice is based on biochemical individuality, the belief that everyone has unique needs. Some of your cancer patients are not given that much pancreatic enzymes because their pancreas is strong and they do not need support in that area. You really examine each person to find out what their unique needs are.

NG: Correct. The doses vary quite widely, depending on the patient.

RC: Roger Williams and other researchers firmly established that we are all biochemically unique. Yet medicine fails to recognize this. Why do you think that is, and why do you think medicine is looking for the one therapy that will suit everyone?

NG: It is the limitations of human thinking. People want to reduce things to simple answers. Nutrition is not a simple answer. There is no simple way to approach even a single individual patient. Everybody is different. Everybody needs a different diet, different doses of supplements, different supplements. The same dose of one supplement will make one patient feel wonderful and make another patient feel very sick.

RC: Let's look at calcium. So many women are taking calcium because they are told that it is going to strengthen their bones. Yet you have said that the misuse of vitamin and mineral supplements are a real problem, and that people don't realize that the wrong nutrient for the wrong person can have profoundly adverse health effects. Why is that? Because of the individual responses to these nutrients?

NG: Yes. In certain patients, calcium can stimulate certain kinds of cancer, like breast cancer. If you look at the statistics epidemiologically, the increase in breast cancer parallels the increase in use of calcium.

RC: As well as the increase in toxins in our environment and the use of synthetic hormones. You also say that for some people, vitamin E is the wrong nutrient and should not be taken.

NG: We have been saying that for years. Everyone laughed at us. I have a lot of respect for the Shute brothers and other people who have researched vitamin E. Yet some free radicals serve a useful function. Too many antioxidants may knock out the beneficial role of free radicals in your body. Free radicals are how our body defends itself against infection. I have seen people on high doses of C and E who develop more infections, not less.

RC: The other point to underscore here is that you believe the reason that studies of nutrients come up with mixed results is not just because, say, vitamin E or C is good for some and fails to help others-- it is because it is good for some and bad for others, and that researchers are not looking for the bad effect, because they are not looking for the effect of nutrients on the autonomic nervous system. A large part of your understanding of the patient comes from looking at which particular portion of the nervous system is dominant, correct?

NG: That's right. The unconscious nervous system does many things in your body: it digests food, controls glandular function, and controls heart rate and body temperature, to name just a few of its actions. This unconscious system is divided into two halves that work in opposition, but together, in helping the body achieve homeostasis. The sympathetic nervous system stimulates the adrenals and thyroid, and inhibits others. The parasympathetic stimulates the liver, the pancreas, and digestive tract, and inhibits others. They work together, although they are in opposition. These are the two nervous systems that together control your day-to-day physiological functioning.

RC: How do you determine which part of the nervous system is dominant, and why is that important to your therapy?

NG: Because out of that we are able to determine which diet and supplements will suit the patient best. Their sympathetic or parasympathetic dominance tells me what kind of program they need.

RC: Let's say a person comes to you who is parasympathetic dominant, and you put them on the wrong diet, will you make things worse?

NG: You can kill them.

RC: Even if it is a vegetarian diet that is low in fat?

NG: Parasympathetic dominant people need red meat three times per day. Putting them on a vegetarian diet is like raising a lion on hay.

RC: Are there personality types associated with these different types of autonomic dominance?

NG: Sympathetic dominants are aggressive, type A businessmen that get up at six and get more done by noon than the rest of us do in the whole day. They are very ambitious, smart, and energetic in the morning. Parasympathetics would like to sleep until noon, and are very creative. Artistic ability tends to be in the parasympathetic side of the nervous system.

RC: Can people change from one side to another?

NG: We are seeing people who are the opposite of their genetic inheritance. Chemicals in the environment have knocked out their strong nervous system. Wrong diets have gummed up their works.

RC: We are told that everyone should go on a diet high in complex carbohydrates. T. Colin Campbell and others suggest this protects against various degenerative diseases. Is this some form of insanity, in light of the ample evidence that we are all biochemically unique?

NG: It is absolute insanity to suggest that the whole human species as different as it is could be put on one diet. The human species occupies every ecological niche from the arctic circle to equatorial rain forests and there are different foods available in these regions, and people have had to adjust. There is no way one diet is suitable for everybody. The Eskimos are one of the most famous meat eating peoples. They live in the Arctic circle. They have no growing season. They have no fruits. They have no vegetables. The only Eskimos that could survive are those that eat a high fat, high protein diet.

RC: The Eskimos are dying off. Don't they thrive on a diet of 80% saturated fat? Is an increase in carbohydrates in their diet killing them?

NG: Yes. And they were among the healthiest people in the world until they switched their diet to a Western one. When they cut their saturated fat consumption from 80% to 40%, they began to develop our pattern of degenerative diseases. For them, fat was the perfect fuel. There was a study that showed that Eskimos lacked the enzymes to digest complex carbohydrates. Zookeepers know that if you raise a lion or tiger on grains and beans it is going to die. Eskimos need red meat as well, to function effectively.

RC: And right now you are doing some controlled trials.

NG: That's right. We are doing controlled clinical trials with pancreatic cancer. Our hope is that once these studies are published and we document that this program can indeed work, the academic medical world will start putting money behind it. Then we can train other doctors to do it.

RC: You don't accept every patient that comes to your door. And it not simply a space or time limitation. Do you reject a patient if their immune system has been destroyed by conventional therapies?

NG: Most of the patients I see have had chemo or radiation. It is a question of amount and the type of cancer where it is being used. RC: There are many books in health food stores which say that the underlying cause of disease is that we are all too acid, in large part because of a meat-based diet, and need to push our body towards a more alkaline state by eating more fruits, vegetables, almonds, millet, etc.

NG: That is absolutely incorrect. Sympathetic dominants tend to be more acid, parasympathetic dominants tend to be too alkaline, and balanced people tend to be somewhere in between. Sympathetic dominants do well on alkalinizing foods like fruits and vegetables. Parasympathetic dominants need acid forming foods, of which red meat is the most powerful.

RC: Dr. Kelley's wife got into trouble with a vegetarian diet, didn't she?

NG: After Kelley cured himself of cancer on a vegetarian diet, he assumed that it was the perfect diet and that the whole world should be on it. He put his wife on this diet to help with her allergies. Initially she did well. Then she began to do worse and worse; He began to make the diet more strictly vegetarian, eventually putting her on all raw fruits and vegetables with no protein at all. She ended up in a near coma. He was confronted with the fact that here he was the great nutrition doctor, and he almost killed his wife with the wrong diet. He was going to have to call an ambulance and put her in the hospital. He figured the only thing he hadn't done was put her on red meat. Initially she refused, but he convinced her. He put some meat in the blender, and fed it to her, and within an hour she was feeling better. She has been eating red meat two to three times per day since. That's almost twenty-five years ago. She has been in excellent health since.

RC: Very few people are looking into the effect of macro- and micronutrients on the autonomic nervous system function. This may turn out to be, as you believe, one of the most important ways our diet and nutrient intake affects health. Dr. Gonzalez, thanks for being with us.

NG: My pleasure, Robert.